Advanced Solid Tumors
Quiénes somos
Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
Estudio de INCB099280 en combinación con adagrasib en adultos con tumores sólidos avanzados portadores de una mutación en KRASG12C.
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
